Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 6.050 | 6.050 | 0.000 |
Stocks | 93.760 | 93.760 | 0.000 |
Bonds | 0.210 | 0.210 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.504 | 21.169 |
Price to Book | 2.311 | 2.532 |
Price to Sales | 2.393 | 2.940 |
Price to Cash Flow | 12.530 | 12.483 |
Dividend Yield | 2.639 | 2.224 |
5 Years Earnings Growth | 11.375 | 11.690 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.160 | 97.348 |
Consumer Cyclical | 0.830 | 0.953 |
Technology | 0.010 | 0.432 |
Number of long holdings: 122
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
GF CSI Medical | CNE1000037P0 | 91.41 | 0.587 | +0.00% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 0.24 | 232.40 | -0.70% | |
Jiangsu Hengrui | CNE0000014W7 | 0.23 | 44.65 | +0.02% | |
WuXi AppTec | CNE1000031K4 | 0.13 | 55.36 | -0.90% | |
TREASURY COUPON BOND 2023 24 | - | 0.10 | - | - | |
TREASURY COUPON BOND 2024 2 | - | 0.10 | - | - | |
Zhangzhou Pientzehuang | CNE000001F21 | 0.09 | 202.51 | +0.75% | |
Aier Eye Hospital Group | CNE100000GR6 | 0.07 | 12.33 | -0.40% | |
Yunnan Baiyao A | CNE0000008X7 | 0.06 | 57.92 | +0.99% | |
Raas Blood A | CNE100000C31 | 0.06 | 6.97 | +0.87% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GF NASDAQ 100 Index Fund QDIII | 14.6B | 24.57 | 11.28 | 18.27 | ||
GF Stable Growth Mixed Assets Fund | 11.62B | 0.10 | -4.40 | 9.02 | ||
GF Tech Pioneer Alloc | 9.44B | 6.85 | -18.33 | - | ||
GF Global Selction Eq QDII | 8.68B | 26.78 | 9.01 | 13.11 | ||
GF YiLiao BaoJian Eq A | 6.01B | -11.23 | -19.75 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review